Novo Nordisk Clinical Trial Call Center

Louisville, Kentucky 40202

0 studies enrolling now · 2 studies all time

What they study most

Acquired Bleeding Disorder, Crohn's Disease, Inflammation, Trauma

Studies at this site

• Safety and Efficacy of NNC 0142-0000-0002 in Subjects With Moderately to Severely Active Crohn's Disease — Completed
• Evaluation of Recombinant Factor VIIa in Patients With Severe Bleeding Due to Trauma — Withdrawn before enrolling